Business with Barry: Risk Management During COVID-19
April 21, 2020
Now that the FDA is allowing unapproved diagnostic tests on the market, how are companies tackling their risk management?
Showing 96 to 100 of 110
April 21, 2020
Now that the FDA is allowing unapproved diagnostic tests on the market, how are companies tackling their risk management?
April 15, 2020
EU Member States are making exceptions for COVID-19, including letting devices on the market with the CE marking. Click to learn more.
April 9, 2020
Learn more about what the European Union is doing to get treatments and vaccines on the market as quickly as possible during the COVID-19 pandemic.
April 2, 2020
Now that we know how the FDA treats drug approvals during COVID-19, let's look at what provisions they've put in place to get medical devices on the market quickly.
March 27, 2020
The FDA typically has very strict guidelines for pharmaceutical manufacturers to follow before their products can be sold on the market. However during times of global crisis, that may not always be the case.